Finance

Lister
CTHRQ:OTCMKTS
Charles & Colvard Ltd
0,0011 USD
0,00%
(0,00) 1 D
23. sep., 15:28:51 GMT-4  ·   USD
Alle symboler
SymbolPrisEndringEndring (%)
Genererer viktig statistikk for CTHRQ …
Markedsverdi
4,92k
Snittvolum
9,77k
Volum
0,00
52 u høy
0,14 USD
52 u lav
0,00 USD
Beta
1,63
Utestående aksjer
4,47 mill.
Antall ansatte
24
Markedsverdi
4,92k
Snittvolum
9,77k
Volum
0,00
52 u høy
0,14 USD
52 u lav
0,00 USD
Beta
1,63
Utestående aksjer
4,47 mill.
Antall ansatte
24
Nyhetssaker
Fra nettkilder og nyhetspartnere
Profil
Charles & Colvard, Ltd., is a publicly traded American company that distributes and manufactures jewelry, founded in 1995 by Charles Eric Hunter under the name C3 Inc., and then run by his brother Jeff Hunter until 2000. The company changed its name to Charles & Colvard in 1999. The company employs 63 people full-time, and generated $32.4 million in revenue during the year ending June 30, 2019, up from $27.91 million in the previous year. Charles & Covard was the first company to produce and sell synthetic moissanite, under U.S. patent US5723391 A, first filed by C3 Inc., North Carolina. Their gemstones are made from silicon carbide crystals, supplied under an exclusive agreement from Cree Inc. since 2014. In June 2019 the company netted $10 million from a secondary public offering. In March 2020, the company was notified that they were at risk of being delisted on NASDAQ, as their share price had been consistently below $1. Don O'Connell was announced CEO in May 2020, taking over after Suzanne T. Miglucci's resignation. The announcement came days after reporting their quarterly earnings, which included a $5.3 million writeoff. Wikipedia
Om Charles & Colvard Ltd
Administrerende direktørDon O'Connell
Ansatte24
Grunnlagt1995
HovedkontorMorrisville, Nord-Carolina, USA
Sektor-
Tidligere rapporterAlle verdier i USD
Loading Previous Earnings...
Inntekt
Nettoinntekt
Alle verdier i USD
juni 2023
sep. 2024
des. 2024
mars 2025
Inntekt
-
3,23 mill.
4,63 mill.
4,05 mill.
Varekostnad
-
2,23 mill.
3,12 mill.
3,12 mill.
Direkte driftskostnader
-
2,23 mill.
3,12 mill.
3,12 mill.
Utgifter til forskning og utvikling
-
-
-
-
Totale kostnader til forskning og utvikling
-
-
-
-
Salgskostnader, generelle kostnader og administrative kostnader
-
3,14 mill.
4,04 mill.
2,90 mill.
Driftskostnader
-
3,14 mill.
4,04 mill.
2,90 mill.
Totale driftskostnader
-
5,37 mill.
7,17 mill.
6,02 mill.
Driftsinntekter
-
−2,14 mill.
−2,54 mill.
−1,97 mill.
Andre ikke-operasjonelle inntekter
-
-
-
-
EBT inkludert uvanlige elementer
-
−2,13 mill.
−2,54 mill.
−1,97 mill.
EBT uten uvanlige elementer
-
−2,13 mill.
−2,54 mill.
−1,97 mill.
Kostnad for inntektsskatt
-
-
-
-
Faktisk avgiftssats
-
-
-
-
Andre driftskostnader
-
-
-
-
Nettoinntekt
-
−2,13 mill.
−2,54 mill.
−1,97 mill.
Netto fortjenestemargin
-
−65,98 %
−54,79 %
−48,73 %
Resultat per aksje
-
-
-
-
Rente- og investeringsinntekter
-
43,64k
38,11k
16,14k
Rentekostnader
-
−38,54k
−35,62k
−21,10k
Netto rentekostnader
-
5,10k
2,49k
−4,96k
Avskrivnings- og amortiseringskostnader
-
-
-
-
EBITDA
-
−1,92 mill.
−2,32 mill.
−1,75 mill.
Gevinst eller tap ved salg av eiendeler
-
-
-
-
AI-innhold kan inneholde feil. Finn ut mer
Google-apper